Utama › Amiloidosis › Missouri
Kajian klinikal Amiloidosis di Missouri
7 kajian untuk Amiloidosis sedang mencari peserta di lokasi di Missouri.
Bandar di Missouri
Teks kajian rasmi (Bahasa Inggeris)
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Kansas City
- Research Site, St Louis
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT06465810TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 85 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07052903DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
- Clinical Trial Site, St Louis
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT07358078Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- St. Luke's Hospital of Kansas City, Kansas City
- Washington University in St. Louis, St Louis
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06563895Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
- Washington University in St. Louis, St Louis
Mengambil pesertaFasa 4
Umur 18 hingga 80 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT07695701A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.
- Research Site, St Louis
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Jul 2026 · NCT07081646MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- St. Luke's Hospital, Kansas City
Mengambil pesertaFasa 3
Umur 18 hingga 90 · Semua jantina · Dikemas kini 27 Mac 2026 · NCT06128629Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.